Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

about

Open sharing of genomic data: Who does it and why?Updating the landscape of direct-to-consumer pharmacogenomic testing.Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

P2860

Q29896620-FE3ADA44-FA81-4E61-BB8E-181D26F79D77 Q40061998-3A6FC069-C6EE-4E2D-8BFC-22E16409E0E1 Q44845654-D9DB23A8-27A3-4884-89C2-815B1E81927F

P2860

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

Item

http://www.wikidata.org/entity/Q37716304

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prescription medication change ...... ersonal Genomics (PGen) Study.

@en

Prescription medication change ...... he Impact of Personal Genomics

@nl

type

Item

label

Prescription medication change ...... ersonal Genomics (PGen) Study.

@en

Prescription medication change ...... he Impact of Personal Genomics

@nl

prefLabel

Prescription medication change ...... ersonal Genomics (PGen) Study.

@en

Prescription medication change ...... he Impact of Personal Genomics

@nl

P1476

Prescription medication change ...... ersonal Genomics (PGen) Study.

@en

P2093

Cathelijne H van der Wouden

http://www.w3.org/2001/XMLSchema#string

Deanna Alexis Carere

http://www.w3.org/2001/XMLSchema#string

J Scott Roberts

http://www.w3.org/2001/XMLSchema#string

Jason L Vassy

http://www.w3.org/2001/XMLSchema#string

P2860

Q28074173

A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.

PharmGKB: the Pharmacogenomics Knowledge Base.

Self-reports of health care utilization compared to provider records.

Effect of direct-to-consumer genomewide profiling to assess disease risk.

Pharmacogenetics: from bench to byte--an update of guidelines.

Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers.

Association between health-service use and multiplex genetic testing

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing

P2888

gim.2016.141

P304

537-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2016.141

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tyler J. VanderWeele

Robert C. Green

Peter Kraft

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27657683

http://www.w3.org/2001/XMLSchema#string

P932

5362351

http://www.w3.org/2001/XMLSchema#string

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

about

P2860

P2860

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932